Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Orchestra BioMed Holdings Inc., 3 years.
Orchestra BioMed Holdings Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Orchestra BioMed Holdings Inc. | Grant or award | +17,327 | — | — |
| Aug 7, 2025 | Orchestra BioMed Holdings Inc. | Grant or award | +15,000 | — | — |
| Jun 24, 2025 | Orchestra BioMed Holdings Inc. | Grant or award | +12,422 | — | — |
| Nov 26, 2024 | Pyxis Oncology Inc. | Open-market purchase | +5,450 | $2.00 | $10,900 |
| Nov 26, 2024 | Pyxis Oncology Inc. | Open-market purchase | +83,400 | $1.96 | $163,464 |
| Jun 20, 2024 | Orchestra BioMed Holdings Inc. | Grant or award | +5,376 | — | — |
| Mar 26, 2024 | Pyxis Oncology Inc. | Grant or award | +328,710 | — | — |
| Nov 29, 2023 | Pyxis Oncology Inc. | Shares withheld for tax | −36,949 | $1.40 | $51,729 |
| Sep 28, 2023 | Pyxis Oncology Inc. | Open-market purchase | +8,000 | $1.87 | $14,960 |
| Sep 27, 2023 | Pyxis Oncology Inc. | Open-market purchase | +6,426 | $1.85 | $11,888 |
| Sep 25, 2023 | Pyxis Oncology Inc. | Open-market purchase | +12,000 | $1.67 | $20,040 |
| Sep 22, 2023 | Pyxis Oncology Inc. | Open-market purchase | +5,000 | $1.74 | $8,700 |
| Sep 7, 2023 | Pyxis Oncology Inc. | Grant or award | +187,793 | — | — |
| Jul 20, 2023 | Orchestra BioMed Holdings Inc. | Grant or award | +11,667 | — | — |
| Apr 12, 2023 | Orchestra BioMed Holdings Inc. | Option exercise | +758 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.